DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205488

Email this page to a colleague

« Back to Dashboard

NDA 205488 describes NATESTO, which is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the NATESTO profile page.

The generic ingredient in NATESTO is testosterone. There are sixty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the testosterone profile page.

Summary for 205488

Tradename:	NATESTO
Applicant:	Acerus
Ingredient:	testosterone
Patents:	5
Formulation / Manufacturing:	see details

Pharmacology for NDA: 205488

Mechanism of Action

Androgen Receptor Agonists

Medical Subject Heading (MeSH) Categories for 205488

Androgens

Suppliers and Packaging for NDA: 205488

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NATESTO	testosterone	GEL, METERED;NASAL	205488	NDA	Acerus Pharmaceuticals Corporation	42667-5511	42667-5511-1	1 APPLICATOR in 1 BOX (42667-5511-1) > 11 g in 1 APPLICATOR

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL, METERED;NASAL			Strength	5.5MG/0.122GM ACTUATION
Approval Date:	May 28, 2014	TE:		RLD:	No
Patent:		Patent Expiration:	Mar 17, 2034	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	NASAL ADMINISTRATION OF A TESTOSTERONE GEL TO A PATIENT TO TREAT THE PATIENT FOR A CONDITION ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
Patent:		Patent Expiration:	Feb 4, 2024	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:		Patent Expiration:	Feb 4, 2024	Product Flag?	Y	Substance Flag?		Delist Request?

Complete Access Available with Subscription